Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

Provided By GlobeNewswire

Last update: Aug 13, 2025

KUALA LUMPUR, Malaysia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines, today announced its second quarter financial results and provided a business update.